Evidence for cytogenetic and fluorescence in situ hybridization risk stratification of newly diagnosed multiple myeloma in the era of novel therapie.
Saved in:
| Title: | Evidence for cytogenetic and fluorescence in situ hybridization risk stratification of newly diagnosed multiple myeloma in the era of novel therapie. |
|---|---|
| Authors: | Kapoor P (AUTHOR), Fonseca R (AUTHOR), Rajkumar SV (AUTHOR), Sinha S (AUTHOR), Gertz MA (AUTHOR), Stewart AK (AUTHOR), Bergsagel PL (AUTHOR), Lacy MQ (AUTHOR), Dingli DD (AUTHOR), Ketterling RP (AUTHOR), Buadi F (AUTHOR), Kyle RA (AUTHOR), Witzig TE (AUTHOR), Greipp PR (AUTHOR), Dispenzieri A (AUTHOR), Kumar S (AUTHOR), Kapoor, Prashant1 (AUTHOR), Fonseca, Rafael (AUTHOR), Rajkumar, S Vincent (AUTHOR), Sinha, Shirshendu (AUTHOR) |
| Source: | Mayo Clinic Proceedings. Jun2010, Vol. 85 Issue 6, p532-537. 6p. |
| Database: | Academic Search Ultimate |
| ISSN: | 00256196 |
|---|---|
| DOI: | 10.4065/mcp.2009.0677 |
